Dr. Mohammad Ahsan Akbar is a distinguished pharmaceutical scientist with expertise in clinical pharmacology, pharmaceutical bioanalysis, gene-based drug delivery, and regulatory affairs. He earned his Ph.D. in Pharmaceutical Sciences from the University of Florida and has an impressive academic portfolio, including over 30 peer-reviewed publications and five book chapters.
Currently, Dr. Akbar serves as a Clinical Pharmacology Reviewer at the U.S. Food and Drug Administration (FDA), where he plays a vital role in the evaluation of NDA, BLA, and IND applications. His work directly supports the advancement of drug development and regulatory science, ensuring the safety and efficacy of pharmaceutical products and upholding public health standards.
Before joining the FDA, Dr. Akbar held academic positions at Marshall University in the United States and the University of Dhaka in Bangladesh, where he developed significant teaching and research expertise.
His academic journey began at the University of Dhaka, where he earned a B. Pharm. and an M. Pharm. in Clinical Pharmacy and Pharmacology, graduating with top honors. Throughout his career, Dr. Akbar has received numerous awards and prestigious fellowships in recognition of his commitment to pharmaceutical sciences.
An active member of the American Association of Bangladeshi Pharmaceutical Scientists (AABPS), Dr. Akbar is dedicated to advancing the field and contributing meaningfully to the scientific community. Outside of his professional endeavors, he enjoys traveling and spending quality time with his family and friends.